Clinical Trial Update: Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation

View source ↗

Summary

This completed clinical trial evaluated dynamic thoracic impedance as a biomarker for predicting heart failure decompensation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Decompensation

Snippet

Sponsor: Charles Porter, MD | Conditions: Heart Failure; With Decompensation | Status: COMPLETED